Recent scientific breakthroughs have transformed the once-dismissed non-coding DNA, or “junk DNA,” into a targeted weapon ...

Explore how oligonucleotides are reshaping therapeutics, diagnostics and CRISPR with rapid, scalable and personalized ...

Over the past two decades, synthetic biology has fueled advancements across a broad range of disciplines, including agriculture, bioremediation, biofuel production, and chemical manufacturing. Today, ...

Discover how KDF is balancing legacy expertise with forward-looking innovation to shape the future of thin-film deposition.

Ginkgo Bioworks (NYSE: DNA) today announced that the company has extended its multi-year strategic partnership with Bayer to ...

Emerging trends in Healthcare Stocks include increasing adoption of gene therapies, advancements in precision medicine, and ...

The new funding comes five months after the completion of an $80 million Series B, and raises total investment in the company ...

Kadimastem enters strategic collaboration with TargetGene to advance next-generation gene-edited cell therapies: Zurich, Switzerland Tuesday, October 28, 2025, 13:00 Hrs [IST] NLS ...

Most current approaches rely on adding nuclear localization signal (NLS) motifs to the ends of Cas9 to facilitate nuclear entry. However, this method is inefficient, and much of the Cas9 that is ...

Spotify’s CHRO on using AI, a 'glocal' strategy, and 'Core Week' has supported the company’s ‘bandmates’ and made a ...

The collaboration will progress under the combined company, NewCelX, upon completion of the anticipated merger ZURICH and NESS ZIONA, Israel, Oct. 27, 2025 /PRNewswire/ -- NLS Pharmaceutics Ltd. (Nasd ...

The collaboration will progress under the combined company, NewCelX, upon completion of the anticipated merger ZURICH and NESS ZIONA, Israel, Oct. 27, 2025 /PRNewswire/ -- NLS Pharmaceutics ...